Remepy
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
$36MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment
AI security and governance platform purpose-built for enterprise AI agents
AI-first clinical enablement company and developer of remote physical examination technology featuring FDA-cleared medical devices
Building AI agents for code review, testing, and governance
Provides AI-native financial platform for CFO's Office across FP&A, cash management, month-end cl...